He will take the helm as the publication's editor-in-chief beginning in July, when longtime AJR Editor Thomas H. Berquist, MD, leaves for retirement, the American Roentgen Ray Society announced this month.

A probable carcinogen NDMA has been found in a diabetes drug metformin, testing by a pharmacy has confirmed. The FDA previously announced it was testing metformin, which helps control blood sugar, for NDMA.

After weighing recommendations from local and global health agencies, the ESR determined it is not in a position to guarantee a safe congress for its attendees. The European Congress of Radiology will now take place July 15-19 in Vienna.

Howard Forman—MD and Yale professor of radiology, biomedical imaging, economics and public health—recently shared his thoughts on the outbreak. 

Hospital CEOs cited financial challenges as their top concern in 2019, according to a new survey from the American College of Healthcare Executives (ACHE).

A shortage of a human drug was reported by the FDA as a result of the coronavirus. The agency has been closely monitoring the supply chain in anticipation that the virus, dubbed COVID-19, would lead to potential drug shortages.

HHS is investigating a potential problem with the first round of diagnostics for coronavirus after fears of contamination at a lab where government tests were sent. Timothy Stenzel, an FDA official and scientist who visited the government lab, sounded the alarm after witnessing procedures that concerned him.

The Supreme Court will listen to the legal challenge to the Affordable Care Act that has been working its way through the lower courts. The court made its decision to hear the case Monday, March 2.